Back

Hippocrat Labs signs South Korea Medisafe distribution deal with Daewoong

Verifying
  • Hippocrat Labs signed a Medisafe distribution agreement with Daewoong Pharmaceutical.
  • The agreement was announced on Oct. 1 for South Korean hospitals.
  • Medisafe uses Hippo Protocol infrastructure and records data integrity on-chain.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.